I agree that this site is using cookies. You can find further informations here.
X
Campestrini, J.
297  results:
Search for persons X
?
1

Optimal Controller Identification for multivariable non-min..:

Huff, D.D. ; Campestrini, L. ; Gonçalves da Silva, G.R..
ISA Transactions.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Comparing MIMO Process Control Methods on a Pilot Plant:

Boeira, E. ; Bordignon, V. ; Eckhard, D..
Journal of Control, Automation and Electrical Systems.  29 (2018)  4 - p. 411-425 , 2018
Link: https://doi.org/10.1007/..
 
?
3

Identifiability Analysis and Prediction Error Identificatio..:

Campestrini, L. ; Eckhard, D. ; Rui, R..
Journal of Control, Automation and Electrical Systems.  25 (2014)  4 - p. 438-447 , 2014
Link: https://doi.org/10.1007/..
 
?
4

Virtual Reference Feedback Tuning for non-minimum phase pla..:

Campestrini, L. ; Eckhard, D. ; Gevers, M..
Automatica.  47 (2011)  8 - p. 1778-1784 , 2011
Link: https://doi.org/10.1016/..
 
?
5

The influence of hepatic impairment on the pharmacokinetics..:

He, Y.-L. ; Sabo, R. ; Campestrini, J....
European Journal of Clinical Pharmacology.  63 (2007)  7 - p. 677-686 , 2007
Link: https://doi.org/10.1007/..
 
?
6

PIII-19The influence of age, gender and BMI on the pharmaco..:

HE, Y ; SABO, R ; WANG, Y...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P63-P63 , 2006
Link: https://doi.org/10.1016/..
 
?
7

PIII-16Lack of pharmacokinetic interaction between Vildagli..:

HE, Y ; SABO, R ; PICARD, F...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P62-P62 , 2006
Link: https://doi.org/10.1016/..
 
?
8

PII-12Absolute bioavailability of vildagliptin in healthy s..:

HE, Y ; SABO, R ; BALEZ, S...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P38-P38 , 2006
Link: https://doi.org/10.1016/..
 
?
9

Mycophenolic Acid Metabolite Profile in Renal Transplant Pa..:

Tedesco-Silva, H. ; Bastien, M.-C. ; Choi, L....
Transplantation Proceedings.  37 (2005)  2 - p. 852-855 , 2005
Link: https://doi.org/10.1016/..
 
?
10

Pharmacokinetics and pharmacodynamics of the DPP-4 inhibito..:

HE, Y ; BALCH, A ; CAMPESTRINI, J...
Clinical Pharmacology & Therapeutics.  77 (2005)  2 - p. P56-P56 , 2005
Link: https://doi.org/10.1016/..
 
?
11

MYCOPHENOLIC ACID METABOLITE PROFILE IN RENAL TRANSPLANT PA..:

Tedesco-Silva, H ; Bastien, M -C. ; Choi, L...
Transplantation.  78 (2004)  - p. 471 , 2004
Link: https://doi.org/10.1097/..
 
?
12

The pharmacokinetics of the novel promotile drug, tegaserod..:

Appel‐Dingemanse, S. ; Horowitz, A. ; Campestrini, J...
Alimentary Pharmacology & Therapeutics.  15 (2001)  7 - p. 937-944 , 2001
Link: https://doi.org/10.1046/..
 
?
13

Effect of food on the bioavailability of triclabendazole in..:

Lecaillon, J. B. ; Godbillon, J. ; Campestrini, J....
British Journal of Clinical Pharmacology.  45 (1998)  6 - p. 601-604 , 1998
Link: https://doi.org/10.1046/..
 
?
14

Fully automated analytical system using liquid—solid extrac..:

Rouan, M.C. ; Campestrini, J. ; Lecaillon, J.B....
Journal of Chromatography A.  456 (1988)  - p. 45-51 , 1988
Link: https://doi.org/10.1016/..
 
?
15

Liquid Chromatographic Determination of Dihydralazine and H..:

Rouan, M.C. ; Campestrini, J.
Journal of Pharmaceutical Sciences.  74 (1985)  12 - p. 1270-1273 , 1985
Link: https://doi.org/10.1002/..
 
1-15